Kronos BioÂ Inc (KRON) Financials

$0.88

$0.00 (0.00%)

As on 16-Jul-2025 09:30EDT

Market cap

$54 Mln

Revenue (TTM)

$9 Mln

P/E Ratio

--

P/B Ratio

0.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	9.19	9.85	6.29	3.08	--	--
Cost of Revenue	0.83	4.26	4.92	4.46	4.08	4.87
Gross Profit	9.19	9.85	6.29	-4.46	-4.08	-4.87
Operating Expenses	79.53	102.74	128.12	137.12	151.40	58.04
Operating Profit (EBIT)	-70.34	-92.89	-121.83	-137.12	-151.40	-58.04
Other Income	--	--	--	3.91	0.32	-26.51
Profit before Tax	-64.49	-86.08	-112.67	-133.20	-151.08	-88.44
Provision for Tax	--	--	4.75	-3.91	-1.98	-24.36
Profit after Tax (Net Income)	-64.49	-86.08	-112.67	-129.29	-149.10	-64.09
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-133.20	-151.08	-88.44

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	79.81	87.58	159.08	244.50	345.10	465.52
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	20.45	21.51	29.51	28.95	32.75	33.59
Current Liabilities	7.88	15.28	24.70	21.49	13.63	12.86
Total Liabilities	116.02	124.36	213.28	294.94	391.48	511.96

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	6.27	9.14	34.50	50.65	43.92	92.16
Current Assets	101.87	115.23	178.78	244.29	347.55	419.80
Total Assets	116.02	124.36	213.28	294.94	391.48	511.96
Total Debt*	24.09	24.90	28.27	31.09	33.76	32.06
Net Current Assets	93.99	99.95	154.08	222.81	333.93	406.95

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-65.44	-78.58	-90.93	-117.92	-37.91
Cash Flow from Investing Activities	--	85.44	66.37	-32.22	63.72	-160.24
Cash from Financing Activities	--	0.25	0.57	0.85	4.46	415.61
Net Cash Inflow / Outflow	--	--	--	-122.30	-49.74	217.47

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-1.07	-1.43	-1.93	-2.29	-2.69	-1.36
Cash EPS ($)	--	-1.40	-1.90	-2.25	-2.66	-1.34
Adjusted Book Value ($)	--	1.45	2.73	4.33	6.23	9.86
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.08	-1.35	-1.61	-2.13	-0.80
Free Cash Flow per Share ($)	--	-1.08	-1.36	-1.62	-2.21	-1.01

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-57.42	-48.68	-39.51	-34.02	-26.99
ROE (%)	-67.54	-69.80	-55.84	-43.86	-36.79	-28.98
ROA (%)	-40.55	-50.99	-44.34	-37.67	-33.01	-20.85
EBIT Margin (%)	-550.46	-644.11	-1,937.50	-4,446.01	--	--
Net Margin (%)	-701.53	-874.08	-1,791.87	-1,848.36	-46,594.06	241.75
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	21.15	0.57	1.04	--	--	--
EBIT Growth (%)	53.53	47.93	11.15	9.38	-78.96	-424.63
Net Profit Growth (%)	44.60	23.60	12.85	13.28	-132.65	-315.66
EPS Growth (%)	46.44	0.26	0.15	0.15	-0.98	-1.50
Book Value Growth (%)	-42.96	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-0.67	-0.65	-0.71	-5.05	-22.01
Price / Book Value	0.67	0.65	0.46	0.37	2.18	3.03
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.81	0.49	0.60	0.86	-2.02	-10.23
Close Price ($)	0.83	0.95	1.25	1.62	13.59	29.87
High Price ($)	1.60	1.60	2.84	14.61	33.39	39.61
Low Price ($)	0.69	0.69	0.73	1.35	11.03	25.50
Market Cap ($ Cr)	53.65	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	0.28	0.18	0.13	0.10	0.07
Short term debt to equity ratio	0.05	0.04	0.04	0.02	0.01	0.00
Current Ratio	12.93	7.54	7.24	11.37	25.51	32.65
Quick Ratio	12.93	--	--	11.85	25.57	36.51
Interest Coverage	-13.30	--	-13.30	-60.51	-91.32	-21.74

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	--	--	18.55	--	--
Asset Turnover	0.06	0.06	0.02	0.01	--	--
Receivable days	--	--	33.23	82.19	--	--
Inventory Days	--	--	-767.80	-456.26	-2,256.70	-1,869.45
Payable days	--	140.96	220.29	247.36	248.27	227.29
Cash Conversion Cycle	--	--	-954.87	-621.42	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.